Alvotech (ALVO)
12.44
+0.02
(+0.16%)
USD |
NASDAQ |
Nov 21, 16:00
12.40
-0.04
(-0.32%)
After-Hours: 20:00
Alvotech Total Assets (Quarterly): 1.233B for Sept. 30, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 1.233B |
| June 30, 2024 | 1.068B |
| March 31, 2024 | 1.061B |
| December 31, 2023 | 950.09M |
| September 30, 2023 | 958.82M |
| June 30, 2023 | 910.66M |
| Date | Value |
|---|---|
| March 31, 2023 | 895.46M |
| December 31, 2022 | 828.44M |
| September 30, 2022 | 683.13M |
| June 30, 2022 | 774.50M |
| December 31, 2021 | 597.98M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
597.98M
Minimum
Dec 2021
1.233B
Maximum
Sep 2024
905.56M
Average
910.66M
Median
Jun 2023
Total Assets (Quarterly) Benchmarks
| Procaps Group SA | 498.55M |
| Johnson & Johnson | 178.29B |
| Pfizer Inc | 219.48B |
| Rigel Pharmaceuticals Inc | 139.42M |
| NovaBay Pharmaceuticals Inc | 3.877M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 1.577B |
| Shareholders Equity (Quarterly) | -343.71M |
| Debt to Equity Ratio | -2.991 |
| Current Ratio | 2.694 |
| Net Debt Paydown Yield | -1.22% |